Humanigen Inc - Company Profile
Powered by 
All the sales intelligence you need on Humanigen Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Humanigen Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Humanigen Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Humanigen Inc (Humanigen), a subsidiary of Taran Therapeutics Inc, is a clinical-stage biopharmaceutical company that develops of immuno-oncology and immunomodulatory antibodies. The company's pipeline products include ifabotuzumab(anti-EphA3) is for the treatment of solid tumor giloblastoma multiforme (GBM), multiple hematologic malignancies; lenzilumab(anti-GM-CSF) targets chronic myelomonocytic leukemia (CMML), acute graft versus host disease (GVHD), hospitalized covid-19 pneumonia (liver- air), hospitalized covid-19 pneumonia (Activ-5/Bet-B), severe asthama, persistent asthama, chimeric antigen receptor (CAR) treatment-related toxicities, rheumatoid arthritis. Humanigen is headquartered in Burlingame, California, the US.
Humanigen Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pipeline | LENZ |
| Lenzilumab(anti-GM-CSF): | Humaneered |
| Chronic Myelomonocytic Leukemia (CMML) | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Humanigen Inc | Arrowhead Pharmaceuticals Inc | Dicerna Pharmaceuticals Inc | HemaCare Corp | InVivo Therapeutics Holdings Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Short Hills | Pasadena | Lexington | Northridge | Cambridge |
| State/Province | New Jersey | California | Massachusetts | California | Massachusetts |
| No. of Employees | 6 | 711 | - | - | 6 |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Cameron Durrant, M.D. | Chairman; Chief Executive Officer | Executive Board | - | - |
| Dale Chappell, M.D. | Chief Scientific Officer; Director | Executive Board | - | - |
| Rainer Boehm, M.D. | Director | Non Executive Board | - | - |
| Ronald Barliant | Director | Non Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer